Imperva stock: buy or sell?

IMPV stock price: $55.74 0.02% At close on January 9th, 2019

Updated on:
January 9th, 2019

4

Imperva shares remained steady 0.02% to $55.74 on January. January was the 4th climbing session in a row, gaining 0.13%.

Imperva, Inc. engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide.

Should I buy Imperva stock?

Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. That's why is so important to choose your own trading strategy that fits your character as inversor. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

None of our preferred buy setups matches with Imperva stock situation right now, therefore this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean IMPV will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is Imperva stock a buy?

Banks and financial institutions post stock ratings everyday. Unfortunately, we couldn't find any rating for IMPV stock for the last month.

Imperva stock analysis

Daily outlook

Imperva ended on January at $55.74 and remained steady a neutral 0.02%.

Imperva shares remained constant 0.02% to $55.74 on January. Since SMA50d and SMA100d crossed up on November, IMPV price climbed $0.04 per share (0.07%). Since last October when IMPV stock price broke up the SMA100d line, it gained $12.68 (29.45%).

IMPV stock chart (daily)

Weekly outlook

Shares of Imperva closed this week at $55.74 and stayed stable a tight 0.11%. For 4 weeks in a row, price soared and marked a profit of 0.49%.

Far behind is the all-time high Imperva hit by mid July 2018 but price is just -3.31% below that top. Since SMA10d and SMA20w crossed up late October 2018, IMPV price climbed $0.41 per share (0.74%). Since early October 2018 when IMPV stock price broke up the SMA20w line, it gained $11.86 (27.03%).

IMPV stock chart (weekly)

Imperva stock price history

Imperva IPO was on January 4th, 2018 at $42.35 per share1. Since then, IMPV stock surged a 31.60%, with an average of 31.60% per year. If you had invested right after IMPV's IPO a $1,000 in Imperva stock in 2018, it would worth $316.00 today.

1: Adjusted price after possible price splits or reverse-splits.

Imperva stock historical price chart

IMPV stock reached all-time highs with a price of $57.65.

Imperva stock price target

Nobody can reliably foresee how stock prices may evolve in the future. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' IMPV stock price predictions in the hope that they will be met as they may be wrong and not met. For the last month we have not detected any price prediction for Imperva stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

After presenting its last earnings report on October, Imperva remained constant a neutral 0.70%. As soon as we get its actual EPS from the earnings report, we will extend this review. Imperva will present its financial report on February. Analysts expect an Earnings per Share (EPS) ratio of $0.14.
IMPV earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2016-Q4-n/a-0.14n/a
2017-Q1-n/a0.01n/a
2017-Q2-n/a-0.1n/a
2017-Q32017-11-080.280.3317.9%
2017-Q42018-02-08-0.130.11n/a
2018-Q12018-04-26-0.2-0.16n/a
2018-Q22018-07-26-0.71-0.58n/a
2018-Q32018-10-31-0.130.09n/a
2018-Q42019-02-060.14n/an/a
2019-Q1-n/an/an/a

Annual financial results

In 2017, Imperva annual revenues climbed an extraordinary 21.65% to $321.72 million USD from $264.46 marked in 2016. In the same way, its earnings margin (compared to sales) boosted to 7.11%, that is $22.87 million.

Imperva presents anual results in December, and to evaluate its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, Imperva TTM sales up to September 2018 were $351.76 and income $-28.14 M USD. If we compare this TTM figures with the last reported annuality, we can review Imperva business evolution since December 2017: Annual turnover up to September, compared to lastest yearly report, escalated a cool 9.34%. Regarding profit margin, Imperva plunged -15.11% to 7.11%

IMPV annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$138 M-$-25.18 M-18.3%-
2014$164 M19.05%$-58.96 M-36.0%134.17%
2015$234 M42.86%$-48.88 M-20.9%-17.10%
2016$264 M12.87%$-70.28 M-26.6%43.77%
2017$322 M21.65%$23 M7.1%-132.54%
TTM $352 M9.34%$-28.14 M-8.0%-223.03%

Quarterly financial results

Imperva posted $91.63 M in sales for 2018-Q3, a 8.06% improvement compared to previous quarter. Reported quarter income marked $1.06 million with a profit margin of 1.15%. Profit margin rocketed a 28.35% compared to previous quarter when profit margin was -27.19%. When comparing revenues to same quarter last year, Imperva sales marked a great gain and soared a 9.23%. Looking back to recent quarterly results, Imperva posted 2 positive quarters in a row.
IMPV quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2016-Q4$78 M-$-9.82 M-12.5%-
2017-Q1$72 M-7.77%$23.08 M31.9%-335.03%
2017-Q2$74 M2.95%$-3.49 M-4.7%-115.12%
2017-Q3$84 M12.69%$-0.37 M-0.4%-89.40%
2017-Q4$91 M8.57%$3.65 M4.0%-1,085.41%
2018-Q1$84 M-7.51%$-9.78 M-11.6%-368.27%
2018-Q2$85 M0.66%$-23.06 M-27.2%135.75%
2018-Q3$92 M8.06%$1.06 M1.2%-104.59%

Imperva ownership

When you are planning to buy shares of a company, it's always worth to review its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Imperva, of all outstanding shares are owned by its staff.

The following table compares ownership indicators for other stocks related to Imperva:

IMPV
Market cap$0.0 M
Total shares0.0 M
Float shares0.0 M
  - Institutional holdings (%)0.0%
  - Insider holdings (%)0.0%
Shares in short selling0.0%

Imperva summary

Wednesday, January 9th, 2019
Open$55.74
Close$55.74
Day range$55.71 - $55.75
Previous close$55.73
Session gain0.02%
Average true range$0.10
50d mov avg$55.65
100d mov avg$51.94
200d mov avg$50.21
Daily pattern
Weekly pattern

Imperva performance

To better understand Imperva performance you must becnhmark its gains with other related stocks in same sector or industry. We chose as the bechmarking frame for Imperva stock.
Stock3m6m12m
IMPVImperva0.69%3.70%0.00%

Imperva competitors

Unfortunately, we could not find any public company that could be defined as Imperva competitor. This doesn't mean Imperva does not have any competitor in the market, it's just we could not detected it.